Answers are grounded in this paper and cite their sources.
This meta-analysis shows improved bioavailability in antiarthritic formulations using wheat starch and Cardiospermum halicacabum, suggesting a path for sustainable drug delivery innovations.
This meta-analysis evaluates the potential of sustainable formulations incorporating wheat starch and Cardiospermum halicacabum (balloon vine) in biodegradable materials for antiarthritic applications. Wheat starch, a biocompatible and biodegradable excipient, demonstrates excellent film-forming properties and controlled drug release capabilities. C. halicacabum, known for its anti-inflammatory and analgesic effects, has shown promise in reducing arthritis symptoms. The integration of these components into biodegradable matrices enhances drug delivery, improves bioavailability, and ensures environmental sustainability. However, challenges such as standardization issues, stability concerns, clinical validation, and manufacturing hurdles need to be addressed. Future research should focus onnano-formulation development, advanced biopolymerblends, long-term clinicalstudies, and regulatory frameworks for sustainable pharmaceuticals. The development of biodegradable antiarthritic formulations aligns with the principles of green pharmacy, reducing environmental burden and promoting eco-friendly drug delivery. This approach supports sustainable sourcing and minimizes the use of synthetic excipients, potentially enhancing patient compliance. The commercialization of these formulations requires advancements in biopolymer extraction and processing technologies to ensure cost- effectiveness and scalability. The growing public demand for eco-friendly pharmaceutical solutions is driving investments in sustainable drug development. In conclusion, the meta- analysis highlights the promising potential of wheat starch and C. halicacabum in sustainable antiarthritic formulations, while emphasizing the need for further research and development to overcome existing challenges and facilitate widespread adoption.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: